Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05465174
Title Nivolumab and DAY101 for Treatment of Craniopharyngioma in Children and Young Adults (PNOC029)
Acronym PNOC029
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sabine Mueller, MD, PhD
Age Groups: adult | child
Covered Countries USA

No variant requirements are available.